The coronavirus has put financial markets worldwide in panic mode. All major stock indices, including the S&P 500, have been seeing a persistent decline over the past week or so. However, even during such turbulent times, a few stocks have been unaffected or are gaining due to the coronavirus. When it comes to more realistic […]...
Motiv Power Systems, delivering a software platform for the electrification of medium-duty trucks and buses, featured its new F-59 chassis at The Work Truck Show 2020. ...
Vir Biotechnology Inc (NASDAQ: VIR) is stepping up its COVID-19 fighting efforts and the quest has rewarded its shareholders.Adding to its existing efforts, Vir announced Wednesday it has expanded its existing collaboration agreement with Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY), a pioneer in a therapeutic area called RNA interference, to develop treatments for COVID-19. The companies have agreed to use Alnylam's recent advances in lung delivery of novel conjugates of siRNA and Vir's infectious disease expertise to develop one or some siRNAs to treat COVID-19 and other coronaviruses as well.Alnylam said it has designed over 350 siRNAs, targeting genomes of SARS-CoV and SARS-CoV-2. It expects to screen these in lab to zero in on potential siRNA lead candidates, which in turn will be evaluated by scientists at Vir, both in lab and animal models before a development candidate is selected.Vir will be in charge of all development and commercialization, and at the...